These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 17216639)
1. Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's disease. Toft M; Mata IF; Ross OA; Kachergus J; Hulihan MM; Haugarvoll K; Stone JT; Blazquez M; Gibson JM; Aasly JO; White LR; Lynch T; Adler CH; Gwinn-Hardy K; Farrer MJ Mov Disord; 2007 Feb; 22(3):389-92. PubMed ID: 17216639 [TBL] [Abstract][Full Text] [Related]
2. R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation. Nichols WC; Marek DK; Pauciulo MW; Pankratz N; Halter CA; Rudolph A; Shults CW; Wojcieszek J; Foroud T; Mov Disord; 2007 Jan; 22(2):254-7. PubMed ID: 17149721 [TBL] [Abstract][Full Text] [Related]
3. Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2. Martí-Massó JF; Ruiz-Martínez J; Bolaño MJ; Ruiz I; Gorostidi A; Moreno F; Ferrer I; López de Munain A Mov Disord; 2009 Oct; 24(13):1998-2001. PubMed ID: 19735093 [TBL] [Abstract][Full Text] [Related]
4. LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901 [TBL] [Abstract][Full Text] [Related]
5. Common variants of LRRK2 are not associated with sporadic Parkinson's disease. Biskup S; Mueller JC; Sharma M; Lichtner P; Zimprich A; Berg D; Wüllner U; Illig T; Meitinger T; Gasser T Ann Neurol; 2005 Dec; 58(6):905-8. PubMed ID: 16254973 [TBL] [Abstract][Full Text] [Related]
6. [Mutation in LRRK2 is associated with familial presentation of Parkinson's disease in a Chilean kindred]. Miranda M Rev Med Chil; 2007 Mar; 135(3):406-7. PubMed ID: 17505590 [No Abstract] [Full Text] [Related]
7. Lrrk2 mutations in South America: A study of Chilean Parkinson's disease. Perez-Pastene C; Cobb SA; Díaz-Grez F; Hulihan MM; Miranda M; Venegas P; Godoy OT; Kachergus JM; Ross OA; Layson L; Farrer MJ; Segura-Aguilar J Neurosci Lett; 2007 Jul; 422(3):193-7. PubMed ID: 17614198 [TBL] [Abstract][Full Text] [Related]
8. G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort. Bras JM; Guerreiro RJ; Ribeiro MH; Januario C; Morgadinho A; Oliveira CR; Cunha L; Hardy J; Singleton A Mov Disord; 2005 Dec; 20(12):1653-5. PubMed ID: 16149095 [TBL] [Abstract][Full Text] [Related]
9. A novel P755L mutation in LRRK2 gene associated with Parkinson's disease. Wu T; Zeng Y; Ding X; Li X; Li W; Dong H; Chen S; Zhang X; Ma G; Yao J; Deng X Neuroreport; 2006 Dec; 17(18):1859-62. PubMed ID: 17179858 [TBL] [Abstract][Full Text] [Related]
10. The biology and pathobiology of LRRK2: implications for Parkinson's disease. Moore DJ Parkinsonism Relat Disord; 2008; 14 Suppl 2():S92-8. PubMed ID: 18602856 [TBL] [Abstract][Full Text] [Related]
11. Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation. Luzón-Toro B; Rubio de la Torre E; Delgado A; Pérez-Tur J; Hilfiker S Hum Mol Genet; 2007 Sep; 16(17):2031-9. PubMed ID: 17584768 [TBL] [Abstract][Full Text] [Related]
12. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Nichols WC; Pankratz N; Hernandez D; Paisán-Ruíz C; Jain S; Halter CA; Michaels VE; Reed T; Rudolph A; Shults CW; Singleton A; Foroud T; Lancet; 2005 Jan 29-Feb 4; 365(9457):410-2. PubMed ID: 15680455 [TBL] [Abstract][Full Text] [Related]
13. Mutations in LRRK2 as a cause of Parkinson's disease. Giasson BI; Van Deerlin VM Neurosignals; 2008; 16(1):99-105. PubMed ID: 18097165 [TBL] [Abstract][Full Text] [Related]
14. [A PARK8 form of Parkinson's disease: a mutational analysis of the LRRK2 gene in Russian population]. Shadrina MI; Illarioshkin SN; Bagyeva GKh; Bespalova EV; Zagorodskaia TB; Slominskiĭ PA; Markova ED; Kliushnikov SA; Limborskaia SA; Ivanova-Smolenskaia IA Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(3):46-50. PubMed ID: 18379513 [TBL] [Abstract][Full Text] [Related]
15. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance. Gaig C; Ezquerra M; Marti MJ; Muñoz E; Valldeoriola F; Tolosa E Arch Neurol; 2006 Mar; 63(3):377-82. PubMed ID: 16533964 [TBL] [Abstract][Full Text] [Related]
16. Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain). Ruiz-Martínez J; Gorostidi A; Ibañez B; Alzualde A; Otaegui D; Moreno F; López de Munain A; Bergareche A; Gómez-Esteban JC; Martí Massó JF Mov Disord; 2010 Oct; 25(14):2340-5. PubMed ID: 20721916 [TBL] [Abstract][Full Text] [Related]
17. Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease. Tan EK; Skipper L; Chua E; Wong MC; Pavanni R; Bonnard C; Kolatkar P; Liu JJ Mov Disord; 2006 Jul; 21(7):997-1001. PubMed ID: 16602113 [TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of LRRK2 functional domains in Brazilian patients with Parkinson's disease. Abdalla-Carvalho CB; Santos-Rebouças CB; Guimarães BC; Campos M; Pereira JS; de Rosso AL; Nicaretta DH; Marinho e Silva M; dos Santos MJ; Pimentel MM Eur J Neurol; 2010 Dec; 17(12):1479-81. PubMed ID: 20443975 [TBL] [Abstract][Full Text] [Related]
19. LRRK2 in Parkinson's disease - drawing the curtain of penetrance: a commentary. Krüger R BMC Med; 2008 Nov; 6():33. PubMed ID: 18986509 [TBL] [Abstract][Full Text] [Related]
20. Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. Farrer MJ; Stone JT; Lin CH; Dächsel JC; Hulihan MM; Haugarvoll K; Ross OA; Wu RM Parkinsonism Relat Disord; 2007 Mar; 13(2):89-92. PubMed ID: 17222580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]